Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
免疫グロブリン変異体
Document Type and Number:
Japanese Patent JP2023523760
Kind Code:
A
Abstract:
本発明は、親ＩｇＡ ＦｃポリペプチドのＦｃ変異体を提供し、ここでＦｃ変異体は、ＦｃαＲに対する変更された結合を示し、Ｆｃ変異体は、親ＦｃポリペプチドのＦｃ領域における少なくとも１つのアミノ酸改変を含む。

More Like This:
WO/2005/118644BINDING MOLECULES CAPABLE OF NEUTRALIZING RABIES VIRUS AND USES THEREOF
JP2024511109Methods for CAR-T delivery of synthetic peptide therapeutics
JP2022119907AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE
Inventors:
Blankenship, John
Guyot, Justin
Holmberg, Brian
Irigaray, Sebastian
Skeleton, Darko
Application Number:
JP2022565970A
Publication Date:
June 07, 2023
Filing Date:
April 29, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Novartis Age
International Classes:
C12N15/13; A61K39/395; A61K45/00; A61P35/00; C07K16/00; C07K16/32; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Reie Ohno



 
Previous Patent: plant-based egg substitute

Next Patent: pharmaceutical process